Radiation grafted membranes

The development of proton-exchange membranes for fuel cells has generated global interest in order to have a potential source of power for stationary and portable applications. The membrane is the heart of a fuel cell and the performance of a fuel cell depends largely on the physico-chemical nature of the membrane and its stability in the hostile environment of hydrogen and oxygen at elevated temperatures. Efforts are being made to develop membranes that are similar to commercial Nafion membranes in performance and are available at an affordable price. The radiation grafting of styrene and its derivatives onto existing polymer films and subsequent sulfonation of the grafted films has been an attractive route for developing these membranes with requiredchemistry and properties. The process of radiation grafting offers enormous possibilities for design of the polymer architecture by careful variation of the irradiation and the grafting conditions. A wide range of crosslinkers are available, which introduce stability to the membrane during its operation in fuel cells. Crosslinking of the base polymer prior to grafting has also been an attractive means of obtaining membranes with better performance. A systematic presentation is made of the grafting process into different polymers,the physical properties of the resultant membranes, and the fuel cell application of these membranes

Chitosan polysaccharide suppress toll like receptor dependent immune response [Çitosan polisakkaridi toll benzeri reseptöre bağlı bağışıklık yanıtını baskılar]

Objectives: Chitosan is a widely used vaccine or anti-cancer delivery vehicle. In this study, we investigated the immunomodulatory effect of chitosan/pIC nanocomplexes on mouse immune cells. Materials and methods: Proliferative and cytotoxic features of chitosan were tested via CCK-8 assay on RAW 264. 7. IL-1β production was assessed via ELISA from PEC supernatants. TNF-α, and NO induction from chitosan treated RAW cells detected by ELISA and Griess assay, respectively. mRNA message levels of TLRs and cytokines on macrophages in response to chitosan/pIC nanocomplex treatments were evaluated by RT-PCR. Results: Results revealed that chitosan is non-toxic to cells, however, proliferative capacities of macrophages were reduced by chitosan administration. Mouse PECs treated with chitosan, led to NLRP3 dependent inflammasome activation as evidenced by dose-dependent IL-1β secretion. Chitosan/pIC nanocomplexes did not improve immunostimulatory action of pIC on RAW cells, since TNF-α and NO productions remained unaltered. Expression levels of several TLRs, CXCL-16 and IFN-α messages from mouse splenocytes were down regulated in response to chitosan/pIC nanocomplex treatment. Conclusion: Our results revealed that chitosan is an anti-proliferative and inflammasome triggering macromolecule on immune cells. Utilization of chitosan as a carrier system is of concern for immunotherapeutic applications. © 2015 Turkish Journal of Immunology

Novel ETFE based radiation grafted poly(styrene sulfonic acid-co-methacrylonitrile) proton conducting membranes with increased stability

Styrene radiation grafted ETFE based proton conducting membranes are subject to degradation under fuel cell operating conditions and show a poor stability. Lifetimes exceeding 250 h can only be achieved with crosslinked membranes. In this study, a novel approach based on the increase of the intrinsic oxidative stability of uncrosslinked membranes is reported. Hence, the co-grafting of styrene with methacrylonitrile (MAN), which possesses a protected α-position and strong dipolar pendant nitrile group, onto 25 μm ETFE base film was investigated. Styrene/MAN co-grafted membranes were compared to a styrene based membrane in durability tests in single H2/O2 fuel cells. It is shown that the incorporation of MAN considerably improves the chemical stability, yielding fuel cell lifetimes exceeding 1000 h. The membrane preparation based on the co-grafting of styrene and MAN offers the prospect of tuning the MAN content and introduction of a crosslinker to enhance the oxidative stability of the resulting fuel cell membranes

Cross-linker effect in ETFE-based radiation-grafted proton-conducting membranes II. Extended fuel cell operation and degradation analysis

In this study the effect of crosslinker (divinylbenzene (DVB)) content on the chemical stability of poly(ethylene-alt-tetrafluoroethylene) (ETFE) based membranes using an H2O2 solution was carried out. Furthermore, the first long term-testing of single H2/O2 cell over 2180h of an MEA assembled using an optimized ETFE-based membrane prepared by radiation-induced grafting of styrene / DVB and subsequent sulfonation with a graft level of 25 % was carried out. The in situ MEA properties were characterized over the testing period using auxiliary current-pulse resistance, electrochemical impedance spectroscopy, polarization and H2 permeation. It is shown that the crosslinking dramatically improves the ex situ chemical stability, while no significant trend with the crosslinker content was observed. The performance of the tested MEA exhibits a decay rate of 13 μV.h-1 in voltage over the testing time at 500 mA.cm-2 at 80°C, while the hydrogen permeation shows a steady increase over time. This indicates clearly that to some extent changes in the membrane morphology occur over the operating time. The local post mortem analysis of the tested membrane reveals that high degradation was observed in areas adjacent to the O2 inlet and in other areas nearb

Fuel-cell performance of multiply-crosslinked polymer electrolyte membranes prepared by two-step radiation technique

A multiply-crosslinked polymer electrolyte membrane was prepared by the radiation-induced co-grafting of styrene and a bis(vinyl phenyl)ethane (BVPE) crosslinker into a radiation-crosslinked polytetrafluoroethylene (cPTFE) film. We then investigated its H2/O2 fuel-cell performance at 60 and 80ºC in terms of the effect of radiation and chemical crosslinking. At 60ºC, all the membranes initially exhibited similar performance, but only the cPTFE-based membranes were durable at 80ºC, indicating the necessity of radiation crosslinking in the PTFE main chains. Importantly, cell performance of the multiply-crosslinked membrane was found high enough to reach that of a Nafion112 membrane. This is probably because the BVPE crosslinks in the graft component improved the membrane-electrode interface in addition to membrane durability. After severe OCV hold tests at 80 and 95ºC, the performance deteriorated, while no significant change was observed in ohmic resistivity. Accordingly, our membranes seemed so chemically stable that an influence on overall performance loss could be negligible

Factors associated with non-invasive ventilation response on the first day of therapy in patients with hypercapnic respiratory failure

BACKGROUND AND AIM: Noninvasive ventilation (NIV) decreases mechanical ventilation indication in the early period of acute hypercapnic respiratory failure (AHcRF) and factors for success have been studied well. But, less is known about the factors influencing the NIV response in the subacute period. This study was aimed to determine the factors influencing the reduction of PaCO(2) levels within first 24 hours of therapy. METHODS: NIV response was defined as reduction of PaCO(2) level below 50 mmHg within first 24 hours. Patients with AHcRF, treated with NIV, were divided into 2 groups according to this criterion; group 1 as the nonresponsive, group 2 as the responsive. The differences in NIV methods and characteristics of the two groups were evaluated and compared in this retrospective study. RESULTS: A total of 100 patients were included in the study; 66 of them in group 1 and 34 in group 2. No significant differences were identified between the length of NIV application and intensive care unit (ICU) stay, intubation and mortality rates, across the groups. Ninety-one percent of the patients in group 2 had received all night long NIV therapy; this was just 74% in group 1 (P=0.036). Results of multivariate analysis showed that while nocturnal application was significantly associated with better response, prior home ventilation and requirement of higher pressure support (PS) levels significantly and independently associated with poorer response to NIV therapy. CONCLUSION: In patients with AHcRF, all night long use of NIV may accelerate healing by improving PaCO(2) reduction within the first 24 hours. A rapid response in PaCO(2) levels should not be expected in patients requiring higher PS levels and using prior home ventilation